Filtered By:
Drug: Methylprednisolone
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 251 results found since Jan 2013.
PRAC Wants Lactose Out of Injectable Methylprednisolone PRAC Wants Lactose Out of Injectable Methylprednisolone
The committee advises against the use of injectable methylprednisolone containing lactose in patients with suspected or known allergy to cow ' s milk proteins.News Alerts
Source: Medscape Medical News Headlines - July 7, 2017 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Alert Source Type: news
Anaphylactic shock with methylprednisolone sodium succinate in a child with short bowel syndrome and cow ’s milk allergy
ConclusionChildren who are highly sensitive to milk may have severe allergic reactions also after exposure to CMP through a different administration route than the oral one. Patients who have food allergies need to pay particular attention to the prescription of drugs and their formulation.
Source: Italian Journal of Pediatrics - November 17, 2017 Category: Pediatrics Source Type: research
Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research
Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?
Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503 | DOI:10.23822/EurAnnACI.1764-1489.261
Source: European Annals of Allergy and Clinical Immunology - July 19, 2022 Category: Allergy & Immunology Authors: E T Korkmaz O Ayd ın D Mungan B A Sin Y S Demirel S Bavbek Source Type: research
